Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Parisa Lotfinejad"'
Autor:
Mohammad Bakhshivand, Farid Ghorbaninezhad, Tohid Kazemi, Parisa Lotfinejad, Vahid Khaze, Jalil Masoudfar, Somayye Mirzaei, Zahra Asadzadeh, Khalil Hajiasgharzadeh, Afshin Derakhshani, Nazila Alizadeh, Behzad Baradaran
Publikováno v:
Acta Medica Iranica, Vol 61, Iss 3 (2023)
The new coronavirus was first reported in China and caused a widespread global outbreak of pneumonia that spread rapidly across this country and many other countries. Acute kidney injury is one of the important complications of COVID-19, which has be
Externí odkaz:
https://doaj.org/article/d2f0ab8bb3a642b0892901a42719a46f
Autor:
Bita Hazhir Karzar, Parisa Lotfinejad, Masumeh Zamanlu, Afshin Khaki Amir, Mohammad Amini, Ali Sheikh Olya Lavasani, Badrossadat Rahnama
Publikováno v:
Crescent Journal of Medical and Biological Sciences, Vol 8, Iss 2, Pp 151-155 (2021)
Objectives: Electromagnetic fields (EMFs) are developing in scientific areas while biologic and immunologic effects have been proven in many studies. The purpose of the present study was to determine the effect of 50 Hz EMFs in the manner of the whol
Externí odkaz:
https://doaj.org/article/667e461eeeb54755975bfeae86a23325
Autor:
Cynthia Aslan, Seyed Hossein Kiaie, Naime Majidi Zolbanin, Parisa Lotfinejad, Reihaneh Ramezani, Fatah Kashanchi, Reza Jafari
Publikováno v:
BMC Biotechnology, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Over the past decade, therapeutic messenger RNAs (mRNAs) have emerged as a highly promising new class of drugs for protein replacement therapies. Due to the recent developments, the incorporation of modified nucleotides in synthetic mRNAs ca
Externí odkaz:
https://doaj.org/article/1e77fac48cd343a78ce687485770ced0
Autor:
Parisa Lotfinejad, Karim Shamsasenjan, Behzad Baradaran, Elham Safarzadeh, Tohid Kazemi, Ali Akbar Movassaghpour
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 20, Iss 6 (2021)
Many studies have been performed about regenerative and immunomodulatory properties of mesenchymal stem cells (MSCs) and their application in different treatment approaches. The present study aimed to investigate the immunomodulatory effect of umbili
Externí odkaz:
https://doaj.org/article/162d587358fb4918b2cc0d454b98e3fd
Autor:
Mahdi Abdoli Shadbad, Negar Hosseinkhani, Zahra Asadzadeh, Afshin Derakhshani, Noora Karim Ahangar, Nima Hemmat, Parisa Lotfinejad, Oronzo Brunetti, Nicola Silvestris, Behzad Baradaran
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
As a unique population of tumor bulk, cancer stem cells have been implicated in tumor relapse and chemoresistance in triple-negative breast cancer (TNBC). Therefore, understanding the phenotype of cancer stem cells can pave the way for introducing no
Externí odkaz:
https://doaj.org/article/b158a4b0eea045069ae8b5f7cf16c58f
Autor:
Parisa Lotfinejad, Tohid Kazemi, Sahar Safaei, Mohammad Amini, Elmira Roshani asl, Elham Baghbani, Siamak Sandoghchian Shotorbani, Farhad Jadidi Niaragh, Afshin Derakhshani, Mahdi Abdoli Shadbad, Nicola Silvestris, Behzad Baradaran
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 138, Iss , Pp 111436- (2021)
Triple-negative breast cancer (TNBC) is an invasive tumor with a high incidence of distant metastasis and poor prognosis. In TNBC cells, high PD-L1 expression can induce an immunosuppressive tumor microenvironment, repressing the anti-tumoral immune
Externí odkaz:
https://doaj.org/article/47d308f0ac074c89a9e99ed5fc7db9c2
Autor:
Hossein Nikkhah, Elham Safarzadeh, Karim Shamsasenjan, Mehdi Yousefi, Parisa Lotfinejad, Mehdi Talebi, Mozhde Mohammadian, Farhoud Golafshan, Ali Akbar Movassaghpour
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 1, Pp 42-48 (2018)
Objective: Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a variety of cell types. They control the process of hematopoiesis by secreting regulatory cytokines and growth factors and by the expression of import
Externí odkaz:
https://doaj.org/article/6725b04e3b104330ae154857dafb03dd
Autor:
Negar Hosseinkhani, Mahdi Abdoli Shadbad, Mohammad Asghari Jafarabadi, Noora Karim Ahangar, Zahra Asadzadeh, Seyede Momeneh Mohammadi, Parisa Lotfinejad, Nazila Alizadeh, Oronzo Brunetti, Rossella Fasano, Nicola Silvestris, Behzad Baradaran
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 19, p 10389 (2021)
Preclinical studies have indicated that T-cell immunoglobulin and ITIM domain (TIGIT) can substantially attenuate anti-tumoral immune responses. Although multiple clinical studies have evaluated the significance of TIGIT in patients with solid cancer
Externí odkaz:
https://doaj.org/article/326807c3622c45bc846f7f8ecc4033f0
Autor:
Parisa Lotfinejad, Mohammad Asghari Jafarabadi, Mahdi Abdoli Shadbad, Tohid Kazemi, Fariba Pashazadeh, Siamak Sandoghchian Shotorbani, Farhad Jadidi Niaragh, Amir Baghbanzadeh, Nafiseh Vahed, Nicola Silvestris, Behzad Baradaran
Publikováno v:
Diagnostics, Vol 10, Iss 9, p 704 (2020)
This meta-analysis aimed to evaluate the prognostic value of tumor-infiltrating lymphocytes (TILs) and programmed death-ligand 1 (PD-L1), their associations with the clinicopathological characteristics, and the association between their levels in pat
Externí odkaz:
https://doaj.org/article/2dc4ca6fec704a6e9fe2610b1a6a36a3
Autor:
Omid Kooshkaki, Afshin Derakhshani, Hossein Safarpour, Souzan Najafi, Parviz Vahedi, Oronzo Brunetti, Mitra Torabi, Parisa Lotfinejad, Angelo Virgilio Paradiso, Vito Racanelli, Nicola Silvestris, Behzad Baradaran
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 14, p 5034 (2020)
Gynecologic cancers account for approximately 11% of the newly diagnosed cancers in women in the United States and for 18% globally. The presence of tumor-infiltrating lymphocytes (TILs) influences the clinical outcome of cancer patients and immune c
Externí odkaz:
https://doaj.org/article/2ad9b43ee70841309ff7a8bb0ac4d763